Listed by the USPTO as PAK, YONG D
Tech Center 1600 • Art Units: 1645 1652 1683
This examiner grants 75% of resolved cases
Yong D. Pak works in Tech Center 1600 and art unit 1645. His record contains 955 resolved cases, with a 74.7% allowance rate and a median of 1051 days to allowance. The case volume supports a useful assessment of the examiner’s recorded outcomes, while the median indicates that prosecution may extend beyond a single response cycle.
The interview lift is 14.2%, indicating a modest recorded association with allowance outcomes. The leading companies are Novozymes A/S, Wisconsin Alumni Research Foundation, and The Regents of the University of California. The leading firms are Kilpatrick Townsend & Stockton LLP - West Coast, Morgan, Lewis & Bockius LLP (WA), and ALSTON & BIRD LLP. Counsel may balance detailed written claim work with selective interview use.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16971209 | A MICROORGANISM PRODUCING A MYCOSPORINE-LIKE AMINO ACID AND A METHOD FOR PRODUCING A MYCOSPORINE-LIKE AMINO ACID USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17780088 | Fungus Strain Having Decreased Viscosity | Final Rejection | IFP Energies Nouvelles |
| 18960980 | SYSTEMS, COMPOSITIONS AND METHODS FOR IDENTIFYING E3 LIGASE SUBSTRATES BY UBIQUITIN BIOTINYLATION | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18891498 | MICROORGANISMS AND METHODS FOR PRODUCING CIS,CIS-MUCONIC ACID | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18737647 | RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18672924 | MICROBES AND METHODS FOR SELECTIVE DETOXIFICATION OF LIGNOCELLULOSIC BIOMASS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18837131 | NOVEL LIPID PEROXIDATION SYSTEM AND METHOD FOR PREPARING BIOFUEL AND BIOPOLYMER USING SAME | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18730984 | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | Final Rejection | The Regents of the University of California |
| 18644618 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF OLEFINIC ESTER | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18870994 | ANTIVIRAL AGENT, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL INFECTION, KIT FOR EVALUATING RISK OF VIRAL INFECTION BECOMING SEVERE, AND METHOD FOR EVALUATING RISK OF VIRAL INFECTION BECOMING SEVERE | Non-Final OA | TOHOKU UNIVERSITY |
| 18023946 | ENZYME DEHYDROXYLATING HYDROXYL GROUP AT 9-POSITION OF UROLITHIN COMPOUND | Non-Final OA | DAICEL CORPORATION |
| 18355776 | METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH GLYCEROL RECYCLING | Non-Final OA | DANSTAR FERMENT AG |
| 18822802 | POLYPEPTIDES | Non-Final OA | Novozymes A/S |
| 18570301 | METHOD FOR CONTROLLING SLIME IN A PULP OR PAPER MAKING PROCESS | Final Rejection | Novozymes A/S |
| 18043532 | PROTEASE VARIANTS WITH IMPROVED SOLUBILITY | Final Rejection | Novozymes A/S |
| 18042282 | VARIANTS OF A FAMILY 44 XYLOGLUCANASE | Non-Final OA | Novozymes A/S |
| 18880021 | IMPROVED DOWNREGULATION OF HISTONE CYTOTOXICITY BY COMPLEX OF NEGATIVELY CHARGED POLYSACCHARIDE AND PROTEASE | Non-Final OA | ACADEMISCH ZIEKENHUIS MAASTRICHT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.7% of resolved applications examined by Yong D Pak were allowed (955 resolved cases), compared with 49.5% across Art Unit 1645 over the last five years.
This examiner's interview lift is +14.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Yong D Pak took 1,051 days on average from filing to allowance.
Yong D Pak examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
